Amgen shared on LinkedIn:
“The oncology community is coming together at the ESMO – European Society for Medical Oncology Congress.
At ESMO26, we are sharing new research from across our oncology portfolio, including data that shows our ongoing commitment to advancing innovation in small cell lung cancer.
Interested in learning more? Swipe through for a selection of Amgen presentations to consider adding to your agenda, and search for abstracts LBA3, 3821P and 3808O to learn more.”
You may also be interested in: 20 Posts Not to Miss from ESMO Congress 2026: Day 1
